UCB partnering with Harvard University to fund research projects to discover and develop antibodies for CNS, immunology, diabetes and metabolic disorders for two years

UCB S.A.

Belgium / Mid-Cap Biopharma ($1-$50 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Harvard University

U.S. / Academic

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced